PT  - JOURNAL ARTICLE
AU  - Robert Wesolowski
AU  - George Thomas Budd
TI  - Use of chemotherapy for patients with bone and soft-tissue sarcomas
AID  - 10.3949/ccjm.77.s1.05
DP  - 2010 Mar 01
TA  - Cleveland Clinic Journal of Medicine
PG  - S23--S26
VI  - 77
IP  - 3 suppl 1
4099  - http://www.ccjm.org/content/77/3_suppl_1/S23.short
4100  - http://www.ccjm.org/content/77/3_suppl_1/S23.full
SO  - Cleve Clin J Med2010 Mar 01; 77
AB  - For patients with bone sarcomas, chemotherapy has a proven role in the primary therapy of osteogenic sarcoma and Ewing sarcoma but no role for chondrosarcoma. Chemotherapy’s role is currently more limited for patients with soft-tissue sarcomas, as it is generally used to palliate metastatic disease in most subtypes of soft-tissue sarcoma and remains largely investigational in the treatment of operable disease. The chemotherapy regimens for musculoskeletal sarcomas often carry significant potential toxicities, so the efficacy of less intensive and less toxic regimens is a focus of ongoing research.